Updates

BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”

Sep 15, 2022

I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will Read More

CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE

Sep 12, 2022

Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with Read More

BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY

Sep 9, 2022

Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance Read More

SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC

Sep 1, 2022

FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually Read More

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

Aug 16, 2022

Biden Administration and Congress Deliver Positive Progress on Longstanding Read More

BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES

Aug 16, 2022

Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with Read More

CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE

Aug 12, 2022

Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Read More

ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT

Aug 8, 2022

Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower Read More

CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

Aug 7, 2022

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Aug 5, 2022

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Read More

SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS

Aug 5, 2022

Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High Read More